Lanean...
Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD)
BACKGROUND: People with chronic obstructive pulmonary disease (COPD) have poor quality of life, reduced survival, and accelerated decline in lung function, especially associated with acute exacerbations, leading to high healthcare costs. Long‐acting bronchodilators are the mainstay of treatment for...
Gorde:
| Argitaratua izan da: | Cochrane Database Syst Rev |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley & Sons, Ltd
2017
|
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481854/ https://ncbi.nlm.nih.gov/pubmed/28631387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011897.pub2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|